InvestorsHub Logo
Followers 45
Posts 16232
Boards Moderated 0
Alias Born 09/16/2012

Re: None

Thursday, 05/23/2024 5:42:03 PM

Thursday, May 23, 2024 5:42:03 PM

Post# of 705660
Will the disciples please inform Nature. Eye rolls.

>>Despite the development of peptide, neoantigen, cell-based and mRNA-based vaccines, progress to advanced clinical trials has been sluggish. Factors contributing to this slow progress include the immunosuppressive microenvironment of the tumour, the presence of the blood–brain barrier and the inherent instability of glioblastoma vaccines, collectively hindering treatment efficacy.

https://www.nature.com/articles/s41578-024-00684-z
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News